SEC FORM 4
$17,931.06
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Sale of 4,066 shares at $4.41 per share.
Reporting Person Reynoso Jamie L. · Officer Title CEO, Medicare Advantage · Transaction Code S
Traded Oct 19, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001839066-26-000057 · filed 2026-10-20 · View filing →